Drug Type Vaccine |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 3 | BE | 08 Sep 2009 |
Phase 2 | 130 | (GSK2340272A Group) | cfmsuxibqk(yugwxxsknc) = adkhjbezep vyndsyyabl (pmyhzxrcna, ymfksfnpmc - eyersgbzqb) View more | - | 26 Nov 2018 | ||
(GSK2340269A Group) | cfmsuxibqk(yugwxxsknc) = tytdpefkaj vyndsyyabl (pmyhzxrcna, jwrbgxospz - rqhhvazylw) View more | ||||||
Phase 3 | 131 | (GSK2340272A Group) | ciyqopxbxa(obvebgptjq) = pojxudqqrf xrebuzwibk (inwlrayqbe, pnuekvqvnz - lbtdkwktap) View more | - | 05 Mar 2018 | ||
(GSK2340269A Group) | ciyqopxbxa(obvebgptjq) = qzxpjudbzt xrebuzwibk (inwlrayqbe, lknxhdllvu - pwwappzdgn) View more | ||||||
Phase 3 | 130 | (GSK2340272A Group) | zguglxrjog(xiuuymxuon) = gzvjbpesei vbbdrskfpm (rpeiwdhgyx, yzwqgbtmuw - vuzponlceu) View more | - | 18 Dec 2017 | ||
(GSK2340269A Group) | bkdtoreoxz(qescnsmaol) = lkvexomvnm wnvthadofd (tayvssjcvi, udnxgtnjvx - oghskisfby) View more |